Home
Reels
Grupos
Páginas
Más
Grupos Páginas Eventos Blogs Financiamiento
Iniciar sesión Registrarse
Night Mode
Biosimilar Uptake: What Drives Adoption of Herceptin Alternatives?
The availability of biosimilars doesn't automatically translate to adoption. Despite regulatory approval and price advantages, uptake of Herceptin biosimilars varies widely across markets, reflecting complex interactions between payer policies, clinician preferences, patient awareness, and healthcare system structures. Understanding what drives adoption is essential for manufacturers,...
0 Commentarios ·0 Acciones ·26 Views ·0 Vista previa
Please log in to like, share and comment!